ArticleZeitschrift fur Rheumatologie2010
[Capillaroscopy. Procedure and nomenclature].
Article in Zeitschrift fur Rheumatologie, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 45 citations in OpenAlex.
- Relation of nailfold capillaries and autoantibodies to mortality in patients with Raynaud's phenomenon: a retrospective analysis.Rheumatology international · 2026Article
- Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud's phenomenon.RMD open · 2023Article
- [Nailfold capillaroscopy-Principles and clinical application].Zeitschrift fur Rheumatologie · 2022Article
- Capillaroscopic features of microangiopathy in rheumatoid arthritis patients with peripheral vascular syndrome.Clinical rheumatology · 2019Article
- [Systemic sclerosis-clinical picture, diagnosis, and treatment].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2019Article
- [Systemic sclerosis-clinical picture, diagnosis, and treatment].Zeitschrift fur Rheumatologie · 2019Article
- Article
- [Systemic lupus erythematosus : Unusual cutaneous manifestations].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2016Review
- Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated?BioMed research international · 2015Review
- [Gender-specific differences in capillaroscopy in healthy persons and patients with inflammatory rheumatic diseases].Zeitschrift fur Rheumatologie · 2014Review
- [Nailfold capillaroscopy].Zeitschrift fur Rheumatologie · 2014Article
- [Is less than 100 Euro sufficient for a capillary microscope?].Zeitschrift fur Rheumatologie · 2013Article
- [Capillaroscopy. An update].Zeitschrift fur Rheumatologie · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capillaroscopy has high diagnostic and prognostic value in autoimmune connective tissue diseases, in particular systemic sclerosis (SSc). Our working group has developed a consensus on nomenclature, technical equipment, procedure, and diagnostic interpretation of results. The following are required: binocular microscopes with at least 20-/50- and 160-/200-fold magnification and digital archiving. Documentation of defined findings is mandatory. The simultaneous occurrence of, e.g. caliber variations, ectasia, ramifications, elongation (length > 350 microm), torsion (at least two crossing segments per capillary loop), sludge, hemorrhage, and edema is of pathological significance. The isolated occurrence of bushy capillaries (multiple ramifications), thrombosis, giant capillary (capillary lumen > 50 microm), and avascular areas also indicates disease. The latter two findings are highly specific for SSc. Other findings are consistent with connective tissue diseases. These standardized definitions increase quality and comparability of nailfold capillaroscopy in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.